This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Lockshin, M. Articles by Derksen, R. Search for Related Content PubMed PubMed Citation Articles by Lockshin, M. Articles by Derksen, R. Social Bookmarking                         What's this?

New developments in lupus-associated antiphospholipid syndrome

The Barbara Volcker Center for Women and Rheumatic Disease, Hospital for Special Surgery, and Weill Medical College of Cornel University, New York, New York, USA

RHWM Derksen

Department of Rheumatology and Clinical Immunology, University Medical Center, Utrecht, The Netherlands

Systemic lupus erythematosus is the disease in which the antiphospholipid syndrome was first described more than 20 years ago and which is the most frequent underlying disorder in secondary antiphospholipid syndrome. With respect to pathogenic concepts and treatment, the subjects of this review, no clear distinction between primary and secondary antiphospholipid syndrome can be made.

Lupus, Vol. 17, No. 5, 443-446 (2008)
DOI: 10.1177/0961203308090032


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				L. Krischock, C. Horsfield, D. D'Cruz, and S. P. A. Rigden Drug-induced lupus and antiphospholipid syndrome associated with cysteamine therapy Nephrol. Dial. Transplant., June 1, 2009; 24(6): 1997 - 1999. [Abstract] [Full Text] [PDF]